Radius Health, Inc. (RDUS)
| Market Cap | 503.52M |
| Revenue (ttm) | 2.82B |
| Net Income (ttm) | -64.30M |
| Shares Out | 28.11M |
| EPS (ttm) | -2.28 |
| PE Ratio | n/a |
| Forward PE | 54.35 |
| Dividend | $0.75 (4.19%) |
| Ex-Dividend Date | Apr 19, 2024 |
| Volume | 309,111 |
| Open | 17.54 |
| Previous Close | 17.64 |
| Day's Range | 17.38 - 17.94 |
| 52-Week Range | 16.90 - 36.64 |
| Beta | 1.61 |
| Analysts | Strong Sell |
| Price Target | 17.00 (-5.08%) |
| Earnings Date | Apr 4, 2024 |
About RDUS
Radius Recycling, Inc. recycles ferrous and nonferrous metal, and manufactures finished steel products worldwide. The company acquires, processes, and recycles salvaged vehicles, rail cars, home appliances, industrial machinery, manufacturing scrap, and construction and demolition scrap. It offers recycled ferrous metal, a feedstock used in the production of finished steel products; and nonferrous products, including mixed metal joint products recovered from the shredding process, such as zorba, zurik, aluminum, copper, stainless steel, nickel,... [Read more]
Financial Performance
Financial StatementsAnalyst Forecast
According to one analyst, the rating for RDUS stock is "Strong Sell" and the 12-month stock price forecast is $17.0.
News
Radius Recycling Reports Second Quarter Fiscal 2024 Financial Results
Nonferrous and Finished Steel Sales Volumes Up Year-Over-Year Increased Cost Reduction Target by $40 Million Radius Board Declares Quarterly Dividend PORTLAND, Ore., April 04, 2024 (GLOBE NEWSWIRE) --...
Second Quarter Fiscal 2024 Preliminary Results and Announcement of Earnings Date
Nonferrous and Finished Steel Sales Volumes Up Year-over-Year Cost Reduction Target Increased PORTLAND, Ore., March 14, 2024 (GLOBE NEWSWIRE) -- Radius Recycling, Inc. (NASDAQ: RDUS) today announced p...
Radius Recycling Named One of the 2024 World's Most Ethical Companies
PORTLAND, Ore.--(BUSINESS WIRE)--Radius Recycling, Inc. (NASDAQ: RDUS), a global leader in metals recycling, has been recognized as one of the 2024 World's Most Ethical Companies by Ethisphere, a worl...
Radius Recycling Reports First Quarter Fiscal 2024 Financial Results
PORTLAND, Ore.--(BUSINESS WIRE)--Schnitzer Steel Industries, Inc. dba Radius Recycling (NASDAQ: RDUS) today reported results for the first quarter of fiscal 2024 ended November 30, 2023. The Company r...
Radius Recycling Announces First Quarter Fiscal 2024 Earnings Date and Webcast Details
PORTLAND, Ore.--(BUSINESS WIRE)--Schnitzer Steel Industries, Inc. dba Radius Recycling (NASDAQ: RDUS) announced that the Company will report financial results for its first quarter fiscal 2024 ended N...
Radius Recycling Publishes Fiscal Year 2023 Sustainability Report
PORTLAND, Ore.--(BUSINESS WIRE)--Schnitzer Steel Industries, Inc. dba Radius Recycling (NASDAQ: RDUS), a global leader in metals recycling, today announced the release of the Company's Fiscal 2023 Sus...
Radius Recycling Executive Included on TIME100 Climate List of the 100 Most Influential Leaders Driving Business Climate Action
PORTLAND, Ore.--(BUSINESS WIRE)--Today, TIME named Schnitzer Steel Industries, Inc. dba Radius Recycling's (NASDAQ: RDUS) Chairman and Chief Executive Officer, Tamara Lundgren, to the inaugural TIME10...
Radius Recycling Reports Fourth Quarter and Fiscal 2023 Financial Results
PORTLAND, Ore.--(BUSINESS WIRE)--Schnitzer Steel Industries, Inc. dba Radius Recycling (NASDAQ: RDUS) today reported results for the fourth quarter of fiscal 2023 ended August 31, 2023. The Company re...
Radius Recycling Announces Fourth Quarter and Fiscal 2023 Earnings Date and Webcast Details
PORTLAND, Ore.--(BUSINESS WIRE)--Schnitzer Steel Industries, Inc. dba Radius Recycling (NASDAQ: RDUS) announced that the Company will report financial results for its fourth quarter and fiscal 2023 en...
EffRx Pharmaceuticals Signs Exclusive Licensing Agreement With Radius Health To Commercialize BINOSTO® In The United States
FREIENBACH, Switzerland--(BUSINESS WIRE)--EffRx Pharmaceuticals SA, a commercial-stage pharmaceutical company focused on the development and commercialization of musculoskeletal and rare diseases medi...
Gurnet Point Capital and Patient Square Capital Complete Their Acquisition of Radius Health, Inc.
CAMBRIDGE, Mass., Aug. 15, 2022 (GLOBE NEWSWIRE) -- Gurnet Point Capital (“Gurnet Point”) and Patient Square Capital (“Patient Square”) announced today the completion of their acquisition of Radius He...
Menarini Group's Elacestrant Granted Priority Review by the U.S. FDA for Patients with ER+/HER2- Advanced or Metastatic Breast Cancer
Elacestrant, if approved, would be the first oral selective estrogen receptor degrader (SERD) to be available for patients suffering from 2L and 3L ER+/HER2- advanced or metastatic breast cancer Submi...
Dave & Busters, USA Truck See Activist Investor Action
These disclosures are from 13Ds filed with the Securities and Exchange Commission. 13Ds are filed within 10 days of an entity's attaining more than 5% in any class of a company's securities.
RADIUS HEALTH INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Radius Health, Inc. - RDUS
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Radius Health, I...
Velan-Repertoire to Withdraw Director Nominations Due to Pending Sale of Radius Health
ALPHARETTA, Ga.--(BUSINESS WIRE)--Velan Capital Investment Management LP and Repertoire Partners LP (together with the other participants in their solicitation, “Velan-Repertoire” or “we”), collective...
Radius Health Publishes Investor Presentation Outlining Company's Progress and Board Process Resulting in Agreement to be Acquired at Significant Premium
BOSTON, July 07, 2022 (GLOBE NEWSWIRE) -- Radius Health, Inc. ("Radius" or the "Company") (Nasdaq: RDUS) today published a detailed investor presentation available at: https://ir.radiuspharm.com/event...
Radius Announces First Patient Randomized in the RAD011 Pivotal Trial for Prader-Willi Syndrome
BOSTON, July 07, 2022 (GLOBE NEWSWIRE) -- Radius Health, Inc. ("Radius" or the "Company") (Nasdaq: RDUS) today announced the first patient has been randomized in the Phase 2/3 pivotal study, SCOUT-015...
INVESTIGATION REMINDER: The Schall Law Firm Encourages Investors in Radius Health, Inc. with Losses to Contact the Firm
Los Angeles, California--(Newsfile Corp. - July 6, 2022) - The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Radiu...
RDUS ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation into the Fairness of the Acquisition of Radius Health, Inc. by Gurnet Point Capital and Patient Square Capital
NEW YORK , July 5, 2022 /PRNewswire/ -- The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased Radius Health, Inc. ("Radius" or the "Company") (Nas...
SHAREHOLDER ALERT: Weiss Law Investigates Radius Health, Inc.
NEW YORK , June 27, 2022 /PRNewswire/ -- Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Radius Health, Inc. ("Radius Health" or...
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Radius Health, Inc. Merger
Wilmington, Delaware--(Newsfile Corp. - June 24, 2022) - Rigrodsky Law, P.A. is investigating Radius Health, Inc. ("Radius") (NASDAQ: RDUS) regarding possible breaches of fiduciary duties and other vi...
Velan-Repertoire Comments on Proposed Sale of Radius Health to Gurnet Point Capital and Patient Square Capital
ALPHARETTA, Ga.--(BUSINESS WIRE)--Velan Capital Investment Management LP and Repertoire Partners LP (together with the other participants in their solicitation, “Velan-Repertoire” or “we”), collective...
Shareholder Alert: Ademi LLP investigates whether Radius Health, Inc. has obtained a Fair Price in its transaction with Gurnet Point and Patient Square
MILWAUKEE , June 23, 2022 /PRNewswire/ -- Ademi LLP is investigating Radius (NASDAQ: RDUS) for possible breaches of fiduciary duty and other violations of law in its transaction with Gurnet Point and ...
Bone Health Focused Radius Health Goes Private In $890M Deal
Radius Health Inc (NASDAQ: RDUS) will be acquired by Gurnet Point Capital and Patient Square Capital in a transaction valued at approximately $890 million, including the assumption of debt and assumin...
RDUS Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sale of Radius Health, Inc. Is Fair to Shareholders
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLP, an investor rights law firm, is investigating whether the sale of Radius Health, Inc. (NASDAQ: RDUS) to Gurnet Point Capital and Patient Square Capital is ...